* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download Slides - Homepage Usask
Globalization and disease wikipedia , lookup
Transmission (medicine) wikipedia , lookup
Childhood immunizations in the United States wikipedia , lookup
Polyclonal B cell response wikipedia , lookup
DNA vaccination wikipedia , lookup
Monoclonal antibody wikipedia , lookup
Molecular mimicry wikipedia , lookup
Common cold wikipedia , lookup
Ebola virus disease wikipedia , lookup
West Nile fever wikipedia , lookup
Orthohantavirus wikipedia , lookup
Viruses and what they do - An overview Wednesday, August 25, 2010 Viruses (Encyclopedia Britannica) ..infectious agents of small size and simple composition that can multiply only in living cells of animals, plants and bacteria. Viruses are obligate parasites that are metabolically inert when they are outside their hosts. They all rely, to varying extents, on the metabolic processes of their hosts to reproduce themselves. The viral diseases we see are due to the effects of this interaction between the virus and its host cell (and/or the host’s response to this interaction). Viral Genomes Single Stranded DNA Double Stranded Nucleic Acid RNA Double Stranded Positive Single Stranded Negative RNA DNA SS RNA genomes • +ve (sense) and -ve (anti-sense) RNA genomes Positive (sense) AUG GCA CGA Negative (anti-sense) UAC CGU GCU met ala arg herpes capsid adeno Virion “naked” virus particle or Virion envelope enveloped Virus or Virion capsomeres Capsid Proteins produced by viruses • Structural proteins • Non-structural proteins Some viral shapes papillomavirus adenovirus “naked” viruses 100 nm 1 nm = 1 millionth of a mm 100 nm = 1 ten thousandth of a mm parvovirus Some viral shapes 1 nm = 1 millionth of a mm 100 nm = 1 ten thousandth of a mm 100 nm influenzavirus parainfluenza virus Enveloped viruses herpesvirus poxvirus Taxonomy • • • • What is it? On what is it based? Is it important? Do I need to remember all the details? International Committee on Taxonomy of Viruses Viruses with ss DNA genomes porcine circovirus Circoviridae canine parvovirus-2 Parvoviridae feline panleukopenia virus porcine parvovirus (SMEDI) Viruses with ds DNA genomes papillomaviruses Papovaviridae Adenoviridae Herpesviridae adenoviruses equine bovine herpesvirus-1,2 herpesviruses -1,4 porcine cytomegalovirus malignant catarrhal fever virus Poxviridae poxviruses African swine fever virus african swine fever virus Viruses with ds RNA genomes rotaviruses Reoviridae bluetongue virus african horse sickness Birnaviridae infectious bursal disease (chickens) infectious pancreatic necrosis (salmonid fish) Viruses with +ve RNA genomes Picornaviridae Caliciviridae Coronaviridae Arteriviridae Flaviviridae Togaviridae foot and mouth disease virus porcine enteroviruses feline calicivirus coronaviruses equine arterivirus, PRRS flaviviruses (WNV) pestiviruses (BVD) equine encephalitis viruses Viruses with -ve RNA genomes Orthomyxoviridae Paramyxoviridae influenzaviruses parainfluenza virus canine distemper virus Hendra, Nipah viruses respiratory syncytial virus Rhabdoviridae rabies virus Filoviridae vesicular stomatitis virus Ebola virus Bunyaviridae Haantan virus Viruses with reverse transcriptase feline leukemia virus Retroviridae feline, bovine immunodeficiency viruses bovine, avian leukosis viruses caprine arthritis-encephalitis virus Hepadnaviridae Isolates, strains, serotypes and groups no selective pressure on internal proteins selective pressure on external viral proteins antibodies to all viral proteins antibodies to external proteins neutralize virus selective pressure on external viral proteins antibodies to all viral proteins antibodies to external proteins neutralize virus selective pressure forces slight change in external proteins virus, including changed virus, passed on to new host selective pressure on external viral proteins antibodies to all viral proteins antibodies to external proteins neutralize virus selective pressure forces slight change in external proteins process repeated, over time….. neutralizes neutralizes neutralizes neutralizes does not neutralize serum from original cat NOTE: Only external proteins change. Internal proteins do not change process repeated, over time same serotype neutralizes neutralizes neutralizes new serotype neutralizes does not neutralize serum from original cat NOTE: Only external proteins change. Internal proteins do not change Serotype - all isolates of a virus that can be neutralized by a common antiserum are said to belong to the same serotype. …..because of changes in external protein (internal proteins do not change) external proteins are called TYPE SPECIFIC antigens internal proteins are called GROUP SPECIFIC antigens process repeated, over time same serotype new serotype different serotypes same group Group and type specific antigens type specific antigen “naked” virus (eg FMDV) enveloped virus (eg influenza, FeLV) group specific antigen Groups, types (sero-types), isolates and ‘strains’ Type -A specific antigen Type -A Type - B Group specific antigen isolate Type - C Group Type - C specific antigen Serotypes and neutralizing antibody (eg. FMDV) A C O SAT1 SAT2 SAT3 Asia serotypes of FMD virus receptor receptor binding protein on viral surface antibodies against receptor binding protein of serotype A will neutralize viruses of serotype A but not of serotype C example - influenza type specific antigen serotype H1 serotype H5 serotype H7 group specific antigen test based on group specific antigen will detect all three vaccination against one serotype will not protect against others Infection of a cell • • • • attachment entry and uncoating viral gene expression genome replication – DNA viruses – RNA viruses • assembly and release – naked viruses – enveloped viruses Distribution of the CCR532 mutation in human populations from PLoS Biology, Nov 2005 Errors in replication lead to “quasispecies” persistent infection mixture of variant viruses (quasispecies) inclusion bodies A B C D Release of virus Release by lysis of cell (cytopathic) or by budding (without death of cell, non-cytopathic) Infection of a cell Stage Biological Host Drug implications defenses intervention Infection of the animal • Entry - the beginning of infection – Local replication vs systemic spread • Consequences of infection – none to illness (signs, symptoms) • Signs and symptoms • Why some animals get sick while others do not • Patterns of disease Why do some infected animals get sick and others don’t? • Viral factors - virulence • Host Factors Viral Factors: Why are some isolates of a virus more likely to cause severe disease than others? determinants of viral virulence Host Factors: • Genetic Resistance – loss of receptors • CCR5-32 mutation and resistance to HIV – variation in immune response genes – genetic defects in defenses Host factors: • age related susceptibility – greater susceptibility of new born animals – greater susceptibility of adults • prior exposure, acquired resistance • maternal protection • concurrent infections, immuno-suppression, increase in susceptible cells Incubation period infection incubation period - time between infection and the appearance of clinical signs Patterns of disease clinical signs virus shedding acute recurrent chronic or persistent slow virus difficult to detect Resistance and Recovery Resistance and recovery • innate resistance – genetic – serum, mucous factors (complement, defensins) • induced resistance – Toll-like receptors (dendritic cells) • Pathogen Associated Molecular Patterns – interferons and inflammatory cytokines • acquired immunity – humoral – cell mediated After the Toll Rush, LAJ O’Neill, Science 303:1481 2004 Interferons I I I I I E antiviral effects infected cell activated factor Induced interferon genes Immune Modulation Acquired anti-viral immunity (antibody) Virus neutralized B Virus infected cell Antibody targets Fc receptor bearing cell To kill virus infected cell Acquired immunity (CMI) perforins CD8 CD4 Apoptosis trigger necrosis apoptosis cytokines virus replication suppressed Prevention of infection and/or disease Protection of the new born animal antibodies (possible CMI as well) in colostrum – maternal immunization – colostrum replacers – implications for immunization of young animals • caution when using modified-live vaccines • interference by maternal antibodies Interference by maternal antibodies * window of susceptibility passive antibody * 2 4 * 6 * 8 weeks after birth * 10 minimum amount needed for protection * 12 interferes with vaccination can vaccinate in this range Prevention of virus infections/disease • vaccination – inactivated vaccines – attenuated vaccines – subunit – vectored – DNA vaccines • management Why vaccination sometimes fails to protect • • • • • improper use genetic differences between animals antigenic differences blocking by maternal antibodies administration following infection (exceptions - rabies) Diagnosis of viral diseases Why?? Sensitivity and Specificity Diagnosis of viral diseases • clinical signs • virus detection • detection of exposure } Laboratory Detection of virus Detection of virus • • • • • • • isolation (isolation +immunological detection) quantitation (plaque assay, TCID50) PCR and real-time PCR haemagglutination (or HAI) ELISA (in clinic or lab) immunological detection (IH or IF) electron microscopy Virus isolation (tissue culture, experimental animals) cultured cells (two dimensional animals) cytopathic effect immunofluorescence (anti-herpesvirus antibody) Virus quantitation (plaques) plaques count plaques (plaque forming unit/ml) Virus quantitation (TCID50, LD50) 10-2 10-3 10-4 10-5 10-6 TCID50 = 104 50% Tissue culture infectious dose primers PCR Viral DNA First cycle BVDV-1a BVDV-2 Second cycle BVDV-1b Twenty cycles million PCR tests offered by PDS, 2009 ($35) • • • • • • • • • • • • Avian influenza Avian paramyxovirus Bovine viral diarrhoea virus Equine influenza Equine herpesvirus (1 vs 4, neurotropic) Influenza A – pan species Malignant catarrhal fever Porcine circovirus PRRS Rotavirus (genotyping) Swine influenza West Nile virus Haemagglutination (HA) virus No virus Haemagglutination Dilution 2 4 prozone 8 16 32 64 128 256 512 1024 titre No virus Enzyme linked immunabsorbant assay (ELISA) Sample to be tested virus capturing antibody Enzyme -> colour Detecting antibody In-clinic ELISAs Feline leukemia And Immunodeficiency viruses Others: canine parvovirus bovine herpesvirus - 1 bovine viral diarrhoea virus equine infectious anemia virus influenza-A porcine respiratory reproductive syndrome virus Immunological detection Immunohistochemistry Immunofluorescence bovine herpesvirus antigens in endothelial cells BHV-1 antigens in neuron In trigeminal ganglion Detection of exposure Detection of exposure or measure or humoral immunity (serology) • virus neutralization • haemagglutination inhibition • ELISA Virus neutralization Serially dilute serum 1/2 1/4 1/8 1/16……….1/512 Add equal amount of virus (100 plaque forming units) to each tube Infect cultured cells Last dilution that can prevent plaque formation is titer -1/2 1/4 1/128 1/256 1/512 No serum HAI Virus HA 8 wks 1 wk Serum dilution 1/20 1/40 1/80 1/160 1/320 1/640 1/1280 -ve control Limitations of serology • detects exposure and not when exposure occurred • for correlation with disease – Paired sera – IgM – CSF Virology Diagnostic Laboratories • PDS, Saskatoon • Veterinary Services Branch, Manitoba Agriculture, Winnipeg • Animal Health Monitoring Lab, Abbotsford • Central Laboratories for Veterinarians Ltd. Calgary Sample collection and submission • Choosing samples - considerations: – alive or dead – suspected pathogen(s), tropism, pathogenesis – phase of disease – virus detection or exposure • Live animals – nasal swabs, transtracheal aspirates, respiratory secretions, scrapings – vesicular fluid, covering epithelium, biopsy from margin of lesion – feces or fecal swabs – clotted and unclotted blood – samples from unaffected animals • dead animals: – collect samples as soon as possible after death – affected organs – gut loops Shipping the samples • transport medium (from lab or buffered saline with 50 µg/ml gentamycin) • 10% buffered formalin - < 1cm thick • plastic, sealed containers, labeled with water proof ink • ice packs vs frozen samples • For PCR – Regular (ice, frozen) – RNALater Samples should be accompanied by • case history and suspected pathogen(s) • treatment, vaccinations, numbers involved • list of specimens Viruses can be useful too • • • • • biological control of pests cancer therapy gene therapy nanotechnology symbiotic virus-host relationships